No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Azepines / administration & dosage
-
Azepines / adverse effects
-
Azepines / therapeutic use*
-
Drug Resistance, Neoplasm
-
Female
-
Humans
-
Lymphoma, B-Cell / drug therapy*
-
Lymphoma, B-Cell / pathology*
-
Lymphoma, Non-Hodgkin / drug therapy*
-
Lymphoma, Non-Hodgkin / mortality
-
Lymphoma, Non-Hodgkin / pathology*
-
Male
-
Middle Aged
-
Protein Kinase Inhibitors / administration & dosage
-
Protein Kinase Inhibitors / adverse effects
-
Protein Kinase Inhibitors / therapeutic use*
-
Pyrimidines / administration & dosage
-
Pyrimidines / adverse effects
-
Pyrimidines / therapeutic use*
-
Recurrence
-
Retreatment
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Azepines
-
MLN 8237
-
Protein Kinase Inhibitors
-
Pyrimidines